Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific; DNA-binding transcription factor binding activity; and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including nervous system development; positive regulation of morphogenesis of an epithelium; and regulation of DNA-templated transcription. Predicted to act upstream of or within several processes, including astrocyte fate commitment; negative regulation of photoreceptor cell differentiation; and positive regulation of macromolecule biosynthetic process. Predicted to be located in cytoplasm. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus. Orthologous to human SOX8 (SRY-box transcription factor 8).
RGD Description
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific; DNA-binding transcription factor binding activity; and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including nervous system development; positive regulation of morphogenesis of an epithelium; and regulation of DNA-templated transcription. Predicted to act upstream of or within several processes, including astrocyte fate commitment; negative regulation of photoreceptor cell differentiation; and positive regulation of macromolecule biosynthetic process. Predicted to be located in cytoplasm. Predicted to be part of transcription regulator complex. Predicted to be active in nucleus. Orthologous to human SOX8 (SRY-box transcription factor 8); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; acrylamide.